On March 30, the PMDA held the “PMDA-ATC COVID-19 related Medical Products Webinar for the Drug Administration of Vietnam (DAV), Vietnam.”
The theme of the webinar was COVID-19 related Medical Products. The PMDA shared information on the Japanese review and pharmacovigilance system and PMDA’s experiences with 11 DAV regulators.
The PMDA continuously contributes to sharing information by seminars and strengthen collaboration with DAV.
See attached program. [22KB]
Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC COVID-19 related Medical Products Webinar 2022 for DAV, Vietnam
Events and Symposia